The belated US FDA approval of the adenosine A(2A) receptor antagonist istradefylline for treatment of Parkinson's disease

Chen, JF; Cunha, RA

Chen, JF (corresponding author), Wenzhou Med Univ, Mol Neuropharmacol Lab, Wenzhou, Peoples R China.

PURINERGIC SIGNALLING, 2020; 16 (2): 167

Abstract

After more than two decades of preclinical and clinical studies, on August 27, 2019, the US Food and Drug Administration (FDA) approved the adenosine ......

Full Text Link